What is Gilead Sciences, Inc’s (NASDAQ:GILD) current market value? Can you beat the fundamentals?
The price of Gilead Sciences, Inc (NASDAQ:GILD) shares last traded on Wall Street rose 1.04% to $98.90. GILD stock price is now -8.78% away from the 50-day moving average and 6.38% away from the 200-day moving average. The market capitalization of the company currently stands at $123.29B. On March 04, 2025, Oppenheimer reiterated its ‘Outperform’ […]
There’s Something Awry at Gilead Sciences, Inc (NASDAQ:GILD) Since Share Price Gets Ahead of Fundamentals
The stock of Gilead Sciences, Inc (NASDAQ:GILD) last traded at $104.21, down -2.00% from the previous session. GILD stock price is now -4.63% away from the 50-day moving average and 13.20% away from the 200-day moving average. The market capitalization of the company currently stands at $129.91B. On March 04, 2025, Oppenheimer reiterated its ‘Outperform’ […]
Gilead Sciences, Inc (GILD) – it’s time to buy. Check out key Indicators
Stocks of Gilead Sciences, Inc (NASDAQ:GILD) traded higher last session on Wall Street, down -0.32% to $104.54. GILD stock price is now -3.68% away from the 50-day moving average and 15.18% away from the 200-day moving average. The market capitalization of the company currently stands at $130.32B. With the price target enhanced from $115 to […]
A secret that hides Gilead Sciences, Inc’s strength (NASDAQ:GILD)
Stocks of Gilead Sciences, Inc (NASDAQ:GILD) traded higher last session on Wall Street, up 2.20% to $103.63. GILD stock price is now -4.01% away from the 50-day moving average and 15.11% away from the 200-day moving average. The market capitalization of the company currently stands at $129.19B. With the price target enhanced from $115 to […]
Do investors have a safe investment in Gilead Sciences, Inc (NASDAQ:GILD)?
The price of Gilead Sciences, Inc (NASDAQ:GILD) shares last traded on Wall Street rose 2.00% to $105.25. GILD stock price is now -2.29% away from the 50-day moving average and 17.33% away from the 200-day moving average. The market capitalization of the company currently stands at $131.21B. With the price target enhanced from $115 to […]
Gilead Sciences, Inc (NASDAQ:GILD): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Gilead Sciences, Inc (NASDAQ:GILD) last traded at $111.79, up 0.57% from the previous session. GILD stock price is now 6.23% away from the 50-day moving average and 27.06% away from the 200-day moving average. The market capitalization of the company currently stands at $139.22B. With the price target enhanced from $115 to […]
Before You Invest In Gilead Sciences, Inc (NASDAQ:GILD), Consider This Metric
Stocks of Gilead Sciences, Inc (NASDAQ:GILD) traded higher last session on Wall Street, up 1.08% to $107.89. GILD stock price is now 3.69% away from the 50-day moving average and 23.60% away from the 200-day moving average. The market capitalization of the company currently stands at $134.36B. With the price target enhanced from $115 to […]
Why Gilead Sciences, Inc (GILD) Should Be On Your Radar Moving Forward
The stock of Gilead Sciences, Inc (NASDAQ:GILD) last traded at $111.44, down -1.69% from the previous session. GILD stock price is now 9.65% away from the 50-day moving average and 29.98% away from the 200-day moving average. The market capitalization of the company currently stands at $138.78B. With the price target enhanced from $115 to […]
The most important numbers to know about Gilead Sciences, Inc (NASDAQ:GILD)
Gilead Sciences, Inc (NASDAQ:GILD) shares traded 1.18% higher at $117.41 on Wall Street last session. GILD stock price is now 17.90% away from the 50-day moving average and 38.85% away from the 200-day moving average. The market capitalization of the company currently stands at $146.22B. With the price target enhanced from $115 to $132, Oppenheimer […]
Gilead Sciences, Inc (GILD) – Mismatched value: Check Out the Fundamental Analysis
In Friday’s Wall Street session, Gilead Sciences, Inc (NASDAQ:GILD) shares traded at $114.31, up 2.07% from the previous session. GILD stock price is now 17.64% away from the 50-day moving average and 37.14% away from the 200-day moving average. The market capitalization of the company currently stands at $142.46B. With the price target maintained at […]
